IRCT20160422027520N17尚未招募3 期
The effects of platelet lysate therapy on cuff tendinopathy
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 75 years(—)
- 性别
- All
入选标准
- •Men and women between the ages of 18 and 75 with cuff tendinopathy
- •The availability of individual during the study period
排除标准
- •People under the age of 18 and over 75 years
- •Pregnant women or women who are breastfeeding
- •People with malignancy,People with severe heart disease, uncontrolled diabetes mellitus, hemorrhagic diseases, history of anemia, arthritis, fibromyalgia and chronic fatigue syndrome
- •Those linked to acetaminophen or Vicodin or a history of drug misuse
- •History of cortisone injections in the last 6 weeks
- •The use of non-steroidal anti-inflammatory drugs 1 week ago
- •Having hemoglobin less than 11 g / dl and platelet count less than 150000 / mµ
- •The use of inhibitors of platelet aggregation and anti-coagulation such as heparin
- •History of cuff surgery in the last 3 months
研究者
相似试验
招募中
2 期
Treatment of knee meniscus with platelet lysisIRCT20160422027520N18Tabriz University of Medical Sciences15
已完成
3 期
Treatment of chronic knee osteoarthritis with platelet lysis and platelet-rich plasmaIRCT20160422027520N10Tabriz University of Medical Sciences25
已完成
不适用
Clinical study of the influence from the platelet rhich plasma (PRP) application on the therapy of the impingement syndrome (IS) of the shoulderM75.4M75.5M75.1Bursitis of shoulderRotator cuff syndromeImpingement syndrome of shoulderDRKS00013326Otto-von-Guericke-Universität MagdeburgUniversitätsklinik für Orthopädie58
招募中
3 期
The Efficacy of Platelet-Rich Plasma in the Treatment of Knee Osteoarthritis: a double-blind randomized trialJPRN-UMIN000016585Department of orthopaedics, Juntendo university80
已完成
不适用
Antiplatelet therapy following peripheral endovascular interventioPeripheral arterial diseaseCardiovascular - Diseases of the vasculature and circulation including the lymphatic systemACTRN12618000523202Aneurin Bevan University Health Board516
